Amit G Pandya

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. doi request reprint Deferasirox for porphyria cutanea tarda: a pilot study
    Amit G Pandya
    Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9190, USA
    Arch Dermatol 148:898-901. 2012
  2. doi request reprint Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method
    Amit G Pandya
    Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9190, USA
    J Am Acad Dermatol 64:78-83, 83.e1-2. 2011
  3. doi request reprint A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women
    Sreedevi Kodali
    Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9190, USA
    J Am Acad Dermatol 63:1030-5. 2010
  4. doi request reprint A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream
    Jag Bhawan
    Department of Dermatology, Boston University School of Medicine, Boston, MA, USA
    Am J Dermatopathol 31:794-8. 2009
  5. ncbi request reprint Tolerability and efficacy of a novel formulation in the treatment of melasma
    Ian L Guevara
    University of Texas Southwestern Medical Center, Dallas, TX, USA
    J Drugs Dermatol 9:215-8. 2010
  6. ncbi request reprint Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma
    Ian L Guevara
    Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Int J Dermatol 42:966-72. 2003
  7. pmc Reliability and convergent validity of two outcome instruments for pemphigus
    Misha Rosenbach
    Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19119, USA
    J Invest Dermatol 129:2404-10. 2009
  8. doi request reprint Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris
    Victoria P Werth
    Department of Dermatology, University of Pennsylvania, 2 Rhodes Pavilion, 3600 Spruce St, Philadelphia, PA 19119, USA
    Arch Dermatol 144:25-32. 2008
  9. doi request reprint Acquired cutis laxa associated with heavy chain deposition disease
    Cynthia R Harrington
    Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 9190, USA
    J Am Acad Dermatol 59:S99-101. 2008
  10. doi request reprint Melasma quality of life measures
    Tiffany J Lieu
    University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9190, USA
    Dermatol Clin 30:269-80, viii. 2012

Collaborators

Detail Information

Publications11

  1. doi request reprint Deferasirox for porphyria cutanea tarda: a pilot study
    Amit G Pandya
    Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9190, USA
    Arch Dermatol 148:898-901. 2012
    ....
  2. doi request reprint Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method
    Amit G Pandya
    Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9190, USA
    J Am Acad Dermatol 64:78-83, 83.e1-2. 2011
    ..The Melasma Area and Severity Index (MASI), the most commonly used outcome measure for melasma, has not been validated...
  3. doi request reprint A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women
    Sreedevi Kodali
    Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9190, USA
    J Am Acad Dermatol 63:1030-5. 2010
    ..Melasma, a common disorder of hyperpigmentation, is often resistant to therapy. Although salicylic acid peels have been reported to be useful for patients with recalcitrant melasma, controlled trials are lacking...
  4. doi request reprint A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream
    Jag Bhawan
    Department of Dermatology, Boston University School of Medicine, Boston, MA, USA
    Am J Dermatopathol 31:794-8. 2009
    ..These results suggest that the risk of skin atrophy with 24-week use of TC cream for the treatment of melasma is very low...
  5. ncbi request reprint Tolerability and efficacy of a novel formulation in the treatment of melasma
    Ian L Guevara
    University of Texas Southwestern Medical Center, Dallas, TX, USA
    J Drugs Dermatol 9:215-8. 2010
    ..Topical agents containing mixtures of hydroquinone and glycolic acid often cause irritation in patients with melasma...
  6. ncbi request reprint Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma
    Ian L Guevara
    Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Int J Dermatol 42:966-72. 2003
    ..Glycolic acid has been added to hydroquinone formulations in the past to enhance their depigmentation effects, but may cause irritation, leading to postinflammatory hyperpigmentation...
  7. pmc Reliability and convergent validity of two outcome instruments for pemphigus
    Misha Rosenbach
    Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19119, USA
    J Invest Dermatol 129:2404-10. 2009
    ..Subset analysis suggests that for this population of mild-to-moderate disease activity, the PDAI captures more variability in cutaneous disease than the ABSIS...
  8. doi request reprint Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris
    Victoria P Werth
    Department of Dermatology, University of Pennsylvania, 2 Rhodes Pavilion, 3600 Spruce St, Philadelphia, PA 19119, USA
    Arch Dermatol 144:25-32. 2008
    ..To determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (PV)...
  9. doi request reprint Acquired cutis laxa associated with heavy chain deposition disease
    Cynthia R Harrington
    Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 9190, USA
    J Am Acad Dermatol 59:S99-101. 2008
    ..Direct immunofluorescence testing of lesional skin demonstrated immunoglobulin G deposition on elastic fibers, suggesting that in some cases, cutis laxa may have an immune-mediated etiopathogenesis...
  10. doi request reprint Melasma quality of life measures
    Tiffany J Lieu
    University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9190, USA
    Dermatol Clin 30:269-80, viii. 2012
    ..This article addresses these methods, which could be useful to those desiring to develop the MELASQOL in other languages...
  11. ncbi request reprint Efficacy of glycolic acid peels in the treatment of melasma
    Mary E Hurley
    Department of Dermatology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9190, USA
    Arch Dermatol 138:1578-82. 2002
    ..Melasma is an acquired hypermelanosis that is often recalcitrant to treatment with hypopigmenting agents...